Koyfin Home > Directory > Health Care > ANI Pharma Inc > EBITDA / Interest Expenses

ANI Pharma Inc EBITDA / Interest Expenses Chart (ANIP)

ANI Pharma Inc annual/quarterly EBITDA / Interest Expenses from 2012 to 2020. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • ANI Pharma Inc EBITDA / Interest Expenses for the quarter ending September 09, 2020 was $6m a 72.58% increase of 4m year over year
  • ANI Pharma Inc EBITDA / Interest Expenses for the last 12 months ending September 09, 2020 was $2m a -124.09% decrease of -2m year over year
  • ANI Pharma Inc Annual EBITDA / Interest Expenses for 2019 was $4m a -11.72% decrease of -1m from 2018
  • ANI Pharma Inc Annual EBITDA / Interest Expenses for 2018 was $5m a -0.76% decrease of 0m from 2017
  • ANI Pharma Inc Annual EBITDA / Interest Expenses for 2017 was $5m a 1.23% increase of 0m from 2016
Other Ratios Metrics:
  • ANI Pharma Inc Total Debt / Capital for the quarter ending December 12, 2018 was $48m a -10.11% decrease of -5m year over year
  • ANI Pharma Inc Other Liabilities for the quarter ending December 12, 2018 was $0m a -404.03% decrease of -2m year over year
  • ANI Pharma Inc Total Debt / Equity for the quarter ending December 12, 2018 was $93m a -21.52% decrease of -20m year over year
View Chart On Koyfin

Quarterly ANIP EBITDA / Interest Expenses Data

09/2020$6m
06/2020$3m
03/2020$2m
12/2019$2m
09/2019$5m
06/2019$6m
03/2019$6m
12/2018$5m
09/2018$5m
06/2018$4m

Annual ANIP EBITDA / Interest Expenses Data

2019$4m
2018$5m
2017$5m
2016$5m
2015$4m
2014$32m
2013$16m
2012$1m
2011$0m